发明名称 |
Form 2 crystalline polymorph of a salt of N-[1-6-(ethynyl-3-oxo-hexahydro-furo[3,2-b]pyrrole-4-carbonyl)-3-methyl-butyl]-4-[5-fluoro-2-(4-methyl-piperazinyl)thiazol-4-yl]-benzamide useful as cysteine protease inhibitor |
摘要 |
There is provided Form 2 crystalline polymorph consisting of N-[1-6-(ethynyl-3-oxo-hexahydro-furo[3,2-b]pyrrole-4-carbonyl)-3-methyl-butyl]-4-[5-fluoro-2-(4-methyl-piperazin-1-yl)thiazol-4-yl]-benzamide monohydrochloride and N-[1-6-(ethynyl-3-oxo-hexahydro-furo[3,2-b]pyrrole-4- carbonyl)-3-methyl-butyl]-4-[5-fluoro-2-(4-methyl-piperazin-1-yl)thiazol-4-yl]-benzamide hydrate monohydrochloride, its use as a medicament and methods for its preparation. |
申请公布号 |
AU2014307850(B8) |
申请公布日期 |
2017.03.02 |
申请号 |
AU20140307850 |
申请日期 |
2014.08.13 |
申请人 |
Medivir AB |
发明人 |
Grabowska, Urszula;Salvadore-Oden, Lourdes;Diaz Perez, Victor M.;Carr, Andrew |
分类号 |
C07D491/048;A61K31/496;A61P19/00 |
主分类号 |
C07D491/048 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|